R1 zooms out of stealth with $77.5M series A to advance chronic kidney disease treatment - Fierce Biotech

3/17/2026

Alfred raises $15M Series A - latamlist.com

1/26/2026

alfred Raises $15M in Series A Funding - FinSMEs

1/26/2026

F-Prime’s ‘State of Robotics 2025’ report shows record $21 billion investment. But is it another bubble? - Robotics & Automation News

11/7/2025

Limitless Raises $10 Million to Expand Decentralized Prediction Markets - Ventureburn

10/21/2025

Arnatar unveils with $52M, dual-modality RNA platform and rare disease asset - Fierce Biotech

8/25/2025

Boom, Bust and Recover: What Happens Next as Biotech VC Cycle Resets - BioSpace

6/4/2025

Here Are The Fintech Companies That Could Go Public In 2025 - Crunchbase News

6/3/2025

Sprinter Health nabs $55M — Fierce Fundraising Tracker - Fierce Healthcare

6/2/2025

Stephen Knight: Investing in Biotech Solutions - Yale Insights

10/31/2024

Wilson Sonsini Advises Novo Holdings and F-Prime Capital on AvenCell’s $112 Million Series B - Wilson Sonsini

10/22/2024

The march toward viable AI use cases - The Financial Revolutionist

7/9/2024

F-Prime Capital Releases its 2024 State of Fintech Report - PR Newswire

2/6/2024

F-Prime’s Ketan Patel on ‘reverse ageism’ in biotech and investing in a downturn - biopharmadive.com

6/30/2023

How the owners of Fidelity get richer at everyday investors’ expense - Reuters

10/5/2016